Alzheimer's disease & dementia

Researchers present new guidelines for diagnosing Alzheimer's

Today at the International Alzheimer's Congress (AAIC) in Amsterdam, new guidelines for diagnosing Alzheimer's disease developed by clinicians and researchers from around the world were presented. In these criteria, the disease ...

Medications

Q&A: Experts discuss pros, cons of new Alzheimer's drug

Patient care teams are preparing to offer lecanemab, a new Alzheimer's disease treatment expected to soon receive approval from the U.S. Food and Drug Administration (FDA), to patients in the coming months.

page 3 from 40